Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 6/2012

01-06-2012 | Review

A Review of Unmet Needs in Obesity Management

Authors: N. Nguyen, J. K. Champion, J. Ponce, B. Quebbemann, E. Patterson, B. Pham, W. Raum, J. N. Buchwald, G. Segato, F. Favretti

Published in: Obesity Surgery | Issue 6/2012

Login to get access

Abstract

The prevalence of obesity continues to escalate in the USA; however, there is no consensus regarding the optimal therapy for obesity. For the vast majority of severely obese patients, conventional medical therapies (i.e., diet, exercise, behavioral counseling) often fail over the long term. Existing pharmacotherapy adjunctive to behavioral therapy has limited effectiveness and an imperfect safety record. In contrast, bariatric surgery has a high degree of weight loss efficacy, yet only a small fraction of the qualifying obese population undergoes these procedures because of the associated perioperative risks and potential late complications. In addition, the role of bariatric surgery is unclear in certain patient populations, such as patients with lower body mass index (BMI, 30–35 kg/m2), the high-risk super-super obese patients (BMI > 60), the morbidly obese adolescent, and obese patients requiring weight reduction in preparation for other procedures, such as orthopedic, transplant, or vascular surgeries. In these circumstances, there is a need for an effective but less invasive treatment to bridge the gap between medical and surgical therapy. This review examines current treatment outcomes, identifies prominent areas of unmet clinical needs, and provides an overview of two minimally invasive “temporary procedures for weight loss” that may eventually address some of the unmet needs in obesity management.
Literature
1.
The Surgeon General's call to action to prevent and decrease overweight and obesity/Office of Disease Prevention and Health Promotion; Centers for Disease Control and Prevention, National Institutes of Health. [Rockville, MD]: U.S. Dept. of Health and Human Services, Public Health Service, Office of the Surgeon General; Washington, D.C., 2001.
2.
3.
4.
Wang Y, Beydoun MA. The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiologic Rev. 2007;29(1):6–28.CrossRef
5.
Flegal KM, Carroll M, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303(3):235–41.PubMedCrossRef
6.
7.
8.
9.
Centers for Disease Control. Behavioral Risk Factor Surveillance System (BRFSS). Differences in prevalence of obesity among Black, White, and Hispanic adults—United States, 2006–2008. Accessible at: http://​www.​cdc.​gov/​brfss. Accessed 23 Feb 2012.
10.
Fontaine KR, Bartlett SJ. Access and use of medical care among obese persons. Obesity Res. 2000;8:403–6.CrossRef
11.
Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat. 2002;246:1–190.
12.
Ogden CL, Carroll M, Curtin L, et al. Prevalence of high body mass index in US children and adolescents, 2007–2008. JAMA. 2010;303(3):242–9.PubMedCrossRef
13.
14.
Howe LD, Galobardes B, Sattar N, et al. Are there socioeconomic inequalities in cardiovascular risk factors in childhood, and are they mediated by adiposity? Findings from a prospective cohort study. Int J Obes (Lond). 2010;34(7):1149–59.CrossRef
15.
Broyles S, Katzmarzyk PT, Srinivasan SR, et al. The pediatric obesity epidemic continues unabated in Bogalusa, Louisiana. Pediatrics. 2010;125(5):900–5.PubMedCrossRef
16.
Swinburn BA. Commentary: closing the disparity gaps in obesity. Int J Epidemiol. 2009;38(2):509–11.PubMedCrossRef
17.
Gastrointestinal Surgery for Severe Obesity. NIH Consensus Statement 1991; 9(1):1-20.
18.
Fried M, Ribaric G, Buchwald JN, et al. Metabolic surgery for the treatment of type 2 diabetes in patients <35kg/m2: an integrative review of early studies. Obes Surg. 2010;20(6):776–90.PubMedCrossRef
19.
Nguyen NT, Magno CP, Lane KT, et al. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg. 2008;207(6):928–34.PubMedCrossRef
20.
Razak F, Anand SS, Shannon H, et al. Defining obesity cut points in a multiethnic population. Circulation. 2007;115:2111–8.PubMedCrossRef
21.
Deurenberg P, Deurenberg-Yap M. Validity of body composition methods across ethnic population groups. Forum Nutr. 2003;56:299–301.PubMed
22.
Saelens BE. Visceral fat is worth measuring and measuring well. Arch Pediatr Adolesc Med. 2008;162(5):491–2.PubMedCrossRef
23.
Misra A, Chowbey P, Makkar BM, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians of India. 2009;57:163–70.
24.
World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications; part 1: diagnosis and classification of diabetes mellitus. Geneva: WHO Department of Non-communicable Disease Surveillance; 1999.
25.
Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005;28(11):2745–9.PubMedCrossRef
26.
Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [published corrections appear in Circulation 2005; 112(17): e297 and 2005; 112(17): e298].
27.
Braverman E, et al. PATH Foundation NY. Obesity under diagnosed when using body mass index. Presented April 23, 2010 at the American Association of Clinical Endocrinologists (AACE) 19th Annual Meeting & Clinical Congress, Boston, MA.
28.
Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U.S.: 1990–1998. Diabetes Care. 2000;23:1278–83.PubMedCrossRef
29.
Willett WC, Manson JE, Stampfer MJ, et al. Weight, weight change and coronary heart disease in women. JAMA. 1995;273:461–5.PubMedCrossRef
30.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.PubMedCrossRef
31.
Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56.e5. review.PubMedCrossRef
32.
Christou NV. Impact of obesity and bariatric surgery on survival. World J Surg. 2009;33(10):2022–7.PubMedCrossRef
33.
Buchwald H, Estok R, Fahrbach K, et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142(4):621–32. review.PubMedCrossRef
34.
Sjöström L, Narbro K, Sjöström CD. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.PubMedCrossRef
35.
Hayden MJ, Dixon ME, Dixon JB, et al. Perceived discrimination and stigmatisation against severely obese women: age and weight loss make a difference. Obes Facts. 2010;3(1):7–14.PubMedCrossRef
36.
Herpertz S, Kielmann R, Wolf AM, et al. Does obesity surgery improve psychosocial functioning? A systematic review. Int J Obes Relat Metab Disord. 2003;27:1300–14.PubMedCrossRef
37.
Deitel M. How much weight loss is sufficient to overcome major co-morbidities? Obes Surg. 2001;11:659.PubMedCrossRef
38.
39.
Astrup A. Dietary management of obesity. J Parenter Enteral Nutr. 2008;32(5):575–7.CrossRef
40.
Christiansen T, Brunn JM, Madsen EL, et al. Weight loss maintenance in severely obese adults after an intensive lifestyle intervention: 2- to 4-year follow-up. Obesity. 2007;15(2):413–20.PubMedCrossRef
41.
Goodrick GK, Foreyt JP. Why treatments for obesity don’t last. JAMA. 1991;91:1243–7.
42.
Sharma M. Behavioral interventions for preventing and treating obesity in adults. Obes Rev. 2007;8:441–9.PubMedCrossRef
43.
Martins C, Strommen M, Stavne OA, et al. Bariatric surgery versus lifestyle interventions for morbid obesity—changes in body weight, risk factors and comorbidities at 1year. Obes Surg. 2011;21(7):841–9.PubMedCrossRef
44.
Avenell A, Brown TJ, Mcgee MA, et al. What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials. J Hum Nutr Diet. 2004;17:317–35.PubMedCrossRef
45.
Tsai AG, Wadden TA. Systematic review: an evaluation of major commercial weight loss programs in the United States. Ann Intern Med. 2005;142:56–66.PubMed
46.
47.
Jeffery RW, Drewnowski A, Epstein LH, et al. Long-term maintenance of weight loss: current status. Health Psychol. 2000;19(1)(suppl):5–16.PubMedCrossRef
48.
Wadden TA, Crerand CE, Brock J. Behavioral treatment of obesity. Psychiatr Clin North Am. 2005;28(1):151–70.PubMedCrossRef
49.
Dansinger ML, Tabsioni A, Wong JB, et al. Meta-analysis: the effect of dietary counseling for weight loss. Ann Intern Med. 2007;147(1):41–50.PubMed
50.
Anderson JW, Grant L, Gotthelf L, et al. Weight loss and long-term follow-up of severely obese individuals treated with an intense behavioral program. Int J Obes. 2007;31(3):488–93.CrossRef
51.
Anderson JW, Conley SB, Nicholas AS. One hundred pound weight losses with an intensive behavioral program: changes in risk factors in 118 patients with long-term follow-up. Am J Clin Nutr. 2007;86(2):301–7.PubMed
52.
Bray GA. Drug management in obesity. In: Buchwald H, Cowan SM, Pories WJ, editors. Surgical Management of Obesity. New York: Saunders; 2007. p. 73–82.
53.
54.
Wadden TA, Butryn ML, Wilson C. Lifestyle modification for the management of obesity. Gastroenterology. 2007;132(6):2226–38.PubMedCrossRef
55.
Luque CA, Rey JA. Sibutramine: a serotonin-norepinephrine reuptake inhibitor for the treatment of obesity. Ann Pharmacother. 1999;33(9):968–78.PubMedCrossRef
56.
Hvizdos KM, Markham A. Orlistat: a review of its use in the management of obesity. Drugs. 1999;58(4):743–60.PubMedCrossRef
57.
Pi-Sunyer F, Aronne LJ, Heshmati HM, et al. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients—RIO-North America: a randomized controlled trial. J Am Med Assoc. 2006;295:761–75.CrossRef
58.
59.
Cummings D, Overduin J, Foster-Schubert KE, et al. Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery. Surg Obes Relat Dis. 2007;3(2):109–15.PubMedCrossRef
60.
Dixon JB, Strauss BJ, Laurie C, et al. Changes in body composition with weight loss: obese subjects randomized to surgical and medical programs. Obesity (Silver Spring, MD). 2007;15:1187–98.CrossRef
61.
Karlsson J, Taft C, Ryden A, et al. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes. 2007;31:1248–61.CrossRef
62.
Nguyen NT, Silver M, Robinson M, et al. Result of a national audit of bariatric surgery performed at academic centers: a 2004 University Health System Consortium Benchmarking Project. Arch Surg. 2006;141:445–9.PubMedCrossRef
63.
Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 2011;253(3):484–7.PubMedCrossRef
64.
DeMaria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Relat Dis. 2007;3:134–40.PubMedCrossRef
65.
Atkinson RL. Proposed standards for judging the success of the treatment of obesity. Ann Intern Med. 1993;119(7 Pt 2):677–80.PubMed
66.
van Gemert WG, Adang EMM, Greve JWM, et al. Quality of life assessment of morbidly obese patients: effect of weight-reducing surgery. AmJ Clin Nutr. 1998;67:197–201.
67.
Nguyen N, Varela EJ, Nguyen T, et al. Quality of life assessment in the morbidly obese. Obes Surg. 2006;16(5):531–3.PubMedCrossRef
68.
Apovian CM, Cummings S, Anderson W, et al. Best practice updates for multidisciplinary care in weight loss surgery. Obesity (Silver Spring). 2009;17(5):871–9.CrossRef
69.
Champion JK, Pories WJ. 2004 ASBS Consensus Conference. Centers of excellence for bariatric surgery. Surg Obes Relat Dis. 2005;1(2):148–51.PubMedCrossRef
70.
Pratt GM, Learn CA, Hughes GD, et al. Demographics and outcomes at American Society for Metabolic and Bariatric Surgery Centers of Excellence. Surg Endosc. 2009;23(4):795–9.PubMedCrossRef
71.
Martin M, Beekley A, Kjorstad R, et al. Socioeconomic disparities in eligibility and access to bariatric surgery: a national population-based analysis. Surg Obes Relat Dis. 2010;6(1):8–15.PubMedCrossRef
72.
Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361:445–54.CrossRef
73.
Afonso BB, Rosenthal R, Li KM, et al. Perceived barriers to bariatric surgery among morbidly obese patients. Surg Obes Relat Dis. 2010;6(1):16–21.PubMedCrossRef
74.
Fernandez Jr AZ, Demaria EJ, Tichansky DS, et al. Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg. 2004;239(5):698–702. discussion 702-3.PubMedCrossRef
75.
Livingston EH, Arterburn D, Schifftner TL, et al. National Surgical Quality Improvement Program analysis of bariatric operations: modifiable risk factors contribute to bariatric surgical adverse outcomes. J Am Coll Surg. 2006;203(5):625–33.PubMedCrossRef
76.
Arterburn D, Livingston EH, Schifftner T, et al. Predictors of long-term mortality after bariatric surgery performed in Veterans Affairs medical centers. Arch Surg. 2009;144(10):914–20.PubMedCrossRef
77.
Bein B, Scholz J. Anaesthesia for adults undergoing non-bariatric surgery. Best Pract Res Clin Anaesthesiol. 2011;25(1):37–51.PubMedCrossRef
78.
Papavramidis T, Kesisoglou I, Orailoglou V, et al. Mega-obese patients weighing more than 250kg: a problematic group. Acta Chir Belg. 2009;109(1):61–4.PubMed
79.
Iannelli A, Schneck AS, Dahman M, et al. Two-step laparoscopic duodenal switch for superobesity: a feasibility study. Surg Endosc. 2009;23(10):2385–9.PubMedCrossRef
80.
El-Koofy NM, Anwar GM, El-Raziky MS, et al. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children. Saudi J Gastroenterol. 2012;18(1):44–9.PubMedCrossRef
81.
Johnson WD, Kroon JJ, Greenway FL, et al. Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001–2006. Arch Pediatr Adolesc Med. 2009;163(4):371–7.PubMedCrossRef
82.
Schwimmer JB, Burwinkle TM, Varni JW. Health-related quality of life of severely obese children and adolescents. JAMA. 2003;289(14):1813–9.PubMedCrossRef
83.
Papavramidis ST, Kotidis EV, Gamvros O. Prader–Willi syndrome-associated obesity treated by biliopancreatic diversion with duodenal switch. Case report and literature review. J Pediatr Surg. 2006;41:1154–8.CrossRef
84.
O'Brien PE, Sawyer SM, Laurie C, et al. Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial. JAMA. 2010;303(6):519–26.PubMedCrossRef
85.
Inge TH, Jenkins TM, Zeller M, et al. Baseline BMI is a strong predictor of nadir BMI after adolescent gastric bypass. J Pediatr. 2010;56(1):103–8.
86.
Woolford SJ, Clark SJ, Gebramariam A, et al. To cut or not to cut: physicians’ perspectives on referring adolescents for bariatric surgery. Obes Surg. 2010;20(7):937–42.PubMedCrossRef
87.
88.
Schauer P, Chand B, Brethauer S. New applications for endoscopy: the emerging field of endoluminal and transgastric bariatric surgery. Surg Endosc. 2007;21:347–56.PubMedCrossRef
89.
Alami RS, Morton JM, Schuster R, et al. Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomized trial. Surg Obes Relat Dis. 2007;3:145–6.CrossRef
90.
Melissas J, Mouzas J, Filis D, et al. The intragastric balloon—smoothing the path to bariatric surgery. Obes Surg. 2006;16:897–902.PubMedCrossRef
91.
Cremieux PY, Buchwald H, Shikora SA, et al. A study on the economic impact of bariatric surgery. Am J Manag Care. 2008;14(9):589–96.PubMed
92.
Meshkinpour H, Hsu D, Farivar S. Effect of gastric bubble as a weight reduction device: a controlled, crossover study. Gastroenterology. 1988;95:589–92.PubMed
93.
Tsesmeli N, Coumaros D. Review of endoscopic devices for weight reduction: old and new balloons and implantable prostheses. Endoscopy. 2009;41(12):1082–9.PubMedCrossRef
94.
Imaz I, Martínez-Cervell C, García-Alvarez EE, et al. Safety and effectiveness of the intra-gastric balloon for obesity: a meta-analysis. Obes Surg. 2008;18:841–6.PubMedCrossRef
95.
Coté GA, Edmundowicz SA. Emerging technology: endoluminal treatment of obesity. Gastrointest Endosc. 2009;70(5):991–9. Review.PubMedCrossRef
96.
Sallet JA, Marchesini JB, Paiva DS, et al. Brazilian multicenter study of the intragastric balloon. Obes Surg. 2004;14(7):991–8.PubMedCrossRef
97.
Busetto L, Segato G, De Luca M, et al. Preoperative weight loss by intragastric balloon in super-obese patients treated with laparoscopic gastric banding: a case–control study. Obes Surg. 2004;14(5):671–6.PubMedCrossRef
98.
Busetto L, Enzi G, Inelmen EM, et al. Obstructive sleep apnea syndrome in morbid obesity: effects of intragastric balloon. Chest. 2005;128(2):618–23.PubMedCrossRef
99.
Musella M, Milone M, Bellini M, et al. The potential role of intragastric balloon in the treatment of obese-related infertility: personal experience. Obes Surg. 2011;21(4):426–30.PubMedCrossRef
100.
Loffredo A, Cappuccio M, de Luca M, et al. Three years experience with the new intragastric balloon, and a preoperative test for success with restrictive surgery. Obes Surg. 2001;11(3):330–3.PubMedCrossRef
101.
Gersin KS, Keller JE, Stefanidis D, et al. Duodenal-jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity. Surg Innov. 2007;14:275–8.PubMedCrossRef
102.
Aguirre V, Stylopoulos N, Grinbaum R, et al. An endoluminal sleeve induces substantial weight loss and normalizes glucose homeostasis in rats with diet-induced obesity. Obesity (Silver Spring). 2008;16(12):2685–92.CrossRef
103.
Tarnoff M, Rodriguez L, Escalona A, et al. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery. Surg Endosc. 2009;23(3):650–6.PubMedCrossRef
104.
Brethauer SA, Hammel JP, Schauer PR. Systematic review of sleeve gastrectomy as staging and primary bariatric procedure. Surg Obes Relat Dis. 2009;5(4):469–75.PubMedCrossRef
Metadata
Title
A Review of Unmet Needs in Obesity Management
Authors
N. Nguyen
J. K. Champion
J. Ponce
B. Quebbemann
E. Patterson
B. Pham
W. Raum
J. N. Buchwald
G. Segato
F. Favretti
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 6/2012
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-012-0634-z

Other articles of this Issue 6/2012

Obesity Surgery 6/2012 Go to the issue

Clinical Report

Evolving Pattern of Laparoscopic Gastric Band Access Port Complications

Clinical Research

Screening of Adult ADHD Among Patients Presenting for Bariatric Surgery

Clinical Research

Intragastric Balloon Fundal or Antral Position Affects Weight Loss and Tolerability

Clinical Report

Transgastric Endoscopic Retrograde Cholangiopancreatography for the Management of Biliary Tract Disease after Roux-en-Y Gastric Bypass Treatment for Obesity

Clinical Report

Psoriasis Following Bariatric Surgery: Clinical Evolution and Impact on Quality of Life on 10 patients

Clinical Research

500 Intragastric Balloons: What Happens 5 Years Thereafter?